IMMX — Immix Biopharma, Inc. stock price, charts and financials

QT89Immix Biopharma, Inc.

Immix Biopharma, Inc. (NASDAQ: IMMX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.33
+0.91+10.81%
OverviewShort InterestFilings
IMMXQT89Immix Biopharma, Inc.·NASDAQ
9.33+10.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 20, 20268-KCurrent report
Jun 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 21, 2026424B5Prospectus
May 21, 20268-KCurrent report
May 21, 2026FWPFree writing prospectus
May 21, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 06, 2026DEF 14ADefinitive proxy statement
Apr 06, 2026ARSAnnual report to shareholders
Apr 06, 2026DEFA14AAdditional proxy soliciting materials
Mar 30, 20268-KCurrent report
Mar 27, 202610-K/AAnnual report (amended)
Mar 25, 202610-KAnnual report
#1 / 25 of 229
Page
▼
/ 10